• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapy.

作者信息

Silverman Gregg J, Weisman Stuart

机构信息

Department of Medicine, University of California, San Diego, La Jolla, CA 92093-0663, USA.

出版信息

Arthritis Rheum. 2003 Jun;48(6):1484-92. doi: 10.1002/art.10947.

DOI:10.1002/art.10947
PMID:12794814
Abstract
摘要

相似文献

1
Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapy.利妥昔单抗治疗与自身免疫性疾病：抗B细胞治疗的前景
Arthritis Rheum. 2003 Jun;48(6):1484-92. doi: 10.1002/art.10947.
2
Anti B cell therapy (rituximab) in the treatment of autoimmune diseases.抗B细胞疗法（利妥昔单抗）在自身免疫性疾病治疗中的应用。
Curr Opin Pharmacol. 2004 Aug;4(4):398-402. doi: 10.1016/j.coph.2004.03.006.
3
B cells as a therapeutic target in autoimmune diseases other than rheumatoid arthritis.B细胞作为类风湿关节炎以外的自身免疫性疾病的治疗靶点。
Rheumatology (Oxford). 2005 May;44 Suppl 2:ii13-ii17. doi: 10.1093/rheumatology/keh618.
4
Monoclonal antibodies and fusion proteins and their complications: targeting B cells in autoimmune diseases.单克隆抗体和融合蛋白及其并发症：自身免疫性疾病中的 B 细胞靶向治疗。
J Allergy Clin Immunol. 2010 Apr;125(4):814-20. doi: 10.1016/j.jaci.2010.02.025.
5
Anti-CD20 therapy and autoimmune disease: therapeutic opportunities and evolving insights.抗CD20疗法与自身免疫性疾病：治疗机遇与不断演变的见解
Front Biosci. 2007 Jan 1;12:2194-206. doi: 10.2741/2222.
6
B cell-targeted therapy in diseases other than rheumatoid arthritis.类风湿关节炎以外疾病的B细胞靶向治疗。
J Rheumatol Suppl. 2005 Feb;73:25-8; discussion 29-30.
7
B-cell depletion for autoimmune thrombocytopenia and autoimmune hemolytic anemia in pediatric systemic lupus erythematosus.儿童系统性红斑狼疮中自身免疫性血小板减少症和自身免疫性溶血性贫血的B细胞清除疗法
Pediatrics. 2009 Jan;123(1):e159-63. doi: 10.1542/peds.2008-2361. Epub 2008 Dec 15.
8
B cell-directed therapies for autoimmune disease and correlates of disease response and relapse.用于自身免疫性疾病的B细胞定向疗法以及疾病反应和复发的相关因素。
J Allergy Clin Immunol. 2008 Jan;121(1):13-21; quiz 22-3. doi: 10.1016/j.jaci.2007.11.030.
9
Prospects for B-cell-targeted therapy in autoimmune disease.自身免疫性疾病中B细胞靶向治疗的前景。
Rheumatology (Oxford). 2005 Feb;44(2):151-6. doi: 10.1093/rheumatology/keh446. Epub 2004 Oct 27.
10
Longterm clinical and immunological effects of anti-CD20 treatment in patients with refractory systemic lupus erythematosus.抗CD20治疗对难治性系统性红斑狼疮患者的长期临床和免疫学影响。
J Rheumatol. 2008 May;35(5):826-33. Epub 2008 Apr 1.

引用本文的文献

1
Successful treatment of amoxicillin-induced linear IgA bullous dermatosis of childhood with rituximab: A case report and review of the literature.利妥昔单抗成功治疗儿童阿莫西林诱发的线状IgA大疱性皮肤病：一例报告并文献复习
JAAD Case Rep. 2025 Jun 9;62:81-85. doi: 10.1016/j.jdcr.2025.05.009. eCollection 2025 Aug.
2
Rituximab in stiff-person syndrome with glutamic acid decarboxylase 65 autoantibody: a systematic review.利妥昔单抗治疗伴谷氨酸脱羧酶65自身抗体的僵人综合征：一项系统评价
J Neurol. 2025 May 24;272(6):417. doi: 10.1007/s00415-025-13157-2.
3
Management of tuberculosis risk, screening and preventive therapy in patients with chronic autoimmune arthritis undergoing biotechnological and targeted immunosuppressive agents.
接受生物技术和靶向免疫抑制剂治疗的慢性自身免疫性关节炎患者的结核病风险管理、筛查及预防性治疗
Front Immunol. 2025 Feb 3;16:1494283. doi: 10.3389/fimmu.2025.1494283. eCollection 2025.
4
Contribution of long-lived plasma cells to antibody-mediated allograft rejection.长寿浆细胞在抗体介导的同种异体移植排斥反应中的作用。
Clin Transplant Res. 2024 Dec 31;38(4):341-353. doi: 10.4285/ctr.24.0047. Epub 2024 Dec 18.
5
A Review of the Occurrence of Rheumatoid Arthritis and Potential Treatments through Medicinal Plants from an Indian Perspective.从印度视角看类风湿关节炎的发生及药用植物的潜在治疗作用综述。
Curr Rheumatol Rev. 2024;20(3):241-269. doi: 10.2174/0115733971268416231116184056.
6
A novel selective spleen tyrosine kinase inhibitor SKI-O-703 (cevidoplenib) ameliorates lupus nephritis and serum-induced arthritis in murine models.新型选择性脾酪氨酸激酶抑制剂 SKI-O-703（西维地滨）改善狼疮肾炎和血清诱导的关节炎小鼠模型。
Clin Exp Immunol. 2023 Mar 8;211(1):31-45. doi: 10.1093/cei/uxac096.
7
Pathophysiology, Diagnosis, and Management of Chronic Spontaneous Urticaria: A Literature Review.慢性自发性荨麻疹的病理生理学、诊断和治疗：文献综述。
Clin Rev Allergy Immunol. 2022 Dec;63(3):381-389. doi: 10.1007/s12016-022-08952-y. Epub 2022 Sep 1.
8
New Insights into the Treatment of Glomerular Diseases: When Mechanisms Become Vivid.肾小球疾病治疗新视角：机制显身手。
Int J Mol Sci. 2022 Mar 24;23(7):3525. doi: 10.3390/ijms23073525.
9
Controversies in Allergy: The Potential Role of Biologics as First-Line Therapy in Eosinophilic Disorders.过敏症争议：生物制剂在嗜酸性疾病中作为一线治疗的潜在作用。
J Allergy Clin Immunol Pract. 2022 May;10(5):1169-1176. doi: 10.1016/j.jaip.2022.01.043. Epub 2022 Feb 12.
10
Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: The BeatMG Study.利妥昔单抗治疗乙酰胆碱受体抗体阳性全身型重症肌无力的2期试验：BeatMG研究
Neurology. 2022 Jan 25;98(4):e376-e389. doi: 10.1212/WNL.0000000000013121.